Yale Cancer Center

Recent papers from Yale Cancer Center

1. Evaluating Effect of Prior Checkpoint Inhibitor Exposure on Disease Control with Enfortumab Vedotin Plus Pembrolizumab in First-Line Metastatic Bladder CancerBiomedicines · 2026
2. A Real-World Model of Multidisciplinary Survivorship Care: Clinical Pathways, Patient-Reported Outcomes, and Implementation Challenges2026
3. Age reshapes selection on melanoma driver mutationsScience Advances · 2026
4. Trends in Racial and Ethnic Representation in the Oncology Trainee WorkforceJAMA Oncology · 2026
5. Real-world treatment patterns and survival outcomes in extensive-stage small cell lung cancer across first-line induction and maintenance therapyThe Oncologist · 2026
6. Using Distributional Cost-Effectiveness Analysis to Improve Equity and EfficiencyJournal of the American College of Cardiology · 2025
7. The speed of sequencing: Rapid molecular testing in acute myeloid leukaemiaBritish Journal of Haematology · 2026
8. Implications of the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline for GLP-1 Receptor Agonist and SGLT2 Inhibitor Eligibility Among US Adults2026
9. CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancerScience Advances · 2026
10. Individual differences and grade-related changes in sensitivity to the statistical structure of word forms in a shallow writing systemReading and Writing · 2026
11. Non-invasive fibrosis tests in Wilson Disease: Insights from the international Wilson Disease Registry and Barcelona Cohort.Clinical and Translational Gastroenterology · 2026
12. Novel framework for the validation of intermediate clinical endpoints in oncology real-world dataJNCI Journal of the National Cancer Institute · 2026
13. Discovery of direct-acting small-molecule RIG-I agonists through creation of a selective CARD activation platformNature Communications · 2026
14. Spatially resolved host and microbiota RNA profiling in the mouse gut using microDBiTNature Communications · 2026
15. Association between Resilience and Financial Toxicity: The Moderating Role of Age, Race and Socioeconomic Factors2026
16. Qualitative study on barriers and facilitators to genetic testing in Hispanic patients with prostate cancerProstate Cancer and Prostatic Diseases · 2026
17. Practical Review of Role and Usage of Corticosteroids in Modern Neuro-Oncology CareNeurology Clinical Practice · 2026
18. Unhealthy alcohol use’s impact on clinical pharmacist-delivered tobacco treatment among persons with HIV: An exploratory analysis of a randomized clinical trialJAIDS Journal of Acquired Immune Deficiency Syndromes · 2026
19. Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALLBlood Advances · 2026
20. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialThe Lancet · 2018